Series A Mandatory Redeemable Preferred Stock | 07/23/2015 | | P | | 100 | A | $100,000 | 100 | I | Held through subsidiaries |
Series A Mandatory Redeemable Preferred Stock | 02/05/2016 | | J | | 29 | D | $102,000 | 71 | I | Held through subsidiaries |
Series A Mandatory Redeemable Preferred Stock | 02/11/2016 | | J | | 41 | D | $102,000 | 30 | I | Held through subsidiaries |
Series B Mandatory Redeemable Preferred Stock | 07/23/2015 | | P | | 400 | A | $100,000 | 400 | I | Held through subsidiaries |
Series B Mandatory Redeemable Preferred Stock | 12/22/2015 | | J | | 160 | D | $102,000 | 240 | I | Held through subsidiaries |
Series B Mandatory Redeemable Preferred Stock | 02/05/2016 | | J | | 71 | D | $102,000 | 169 | I | Held through subsidiaries |
Series B Mandatory Redeemable Preferred Stock | 02/11/2016 | | J | | 99 | D | $102,000 | 70 | I | Held through subsidiaries |
4.51% Series C Senior Secured Notes due October 15, 2023 | 12/18/2015 | | J | | 4,941,176.47 | D | $5,040,000 | $25,058,823.53 | I | Held through subsidiaries |
4.51% Series C Senior Secured Notes due October 15, 2023 | 02/04/2016 | | J | | 3,813,299.24 | D | $3,889,565.23 | $21,245,524.29 | I | Held through subsidiaries |
4.51% Series C Senior Secured Notes due October 15, 2023 | 02/11/2016 | | J | | 3,159,590.8 | D | $3,222,782.62 | $18,085,933.49 | I | Held through subsidiaries |
4.51% Series C Senior Secured Notes due October 15, 2023 | 02/12/2016 | | J | | 1,198,465.48 | D | $1,222,434.79 | $16,887,468.01 | I | Held through subsidiaries |
4.66% Series D Senior Secured Notes due October 15, 2025 | 12/18/2015 | | J | | 6,400,000 | D | $6,528,000 | $33,600,000 | I | Held through subsidiaries |
4.66% Series D Senior Secured Notes due October 15, 2025 | 02/04/2016 | | J | | 5,113,043.48 | D | $5,215,304.35 | $28,486,956.52 | I | Held through subsidiaries |
4.66% Series D Senior Secured Notes due October 15, 2025 | 02/11/2016 | | J | | 4,236,521.73 | D | $4,321,252.16 | $24,250,434.79 | I | Held through subsidiaries |
4.66% Series D Senior Secured Notes due October 15, 2025 | 02/12/2016 | | J | | 1,606,956.52 | D | $1,639,095.65 | $22,643,478.27 | I | Held through subsidiaries |